Summary

The global Exosome Drug Delivery Services market size was US$ 1402 million in 2025 and is forecast to reach a readjusted size of US$ 2455 million by 2032 with a CAGR of 8.5% during the forecast period 2026-2032.
Exosomes are a type of small vesicles secreted by cells, which carry biological molecules such as proteins, nucleic acids, and lipids. Exosomes have natural intracellular information transmission and regulatory functions, and therefore have attracted widespread attention in the field of drug delivery. Exosome drug delivery service is a professional service that provides exosomes for drug delivery and treatment.
Exosome drug delivery services, a cutting-edge sector in biopharmaceuticals, are experiencing rapid growth due to the inherent advantages of exosomes, such as low immunogenicity and strong tissue penetration. This market encompasses the entire process of exosome isolation and purification, drug loading, and functional validation.
North America is currently the world's largest market, holding approximately 45%-53% of the global market share thanks to its first-mover advantage and well-developed industry ecosystem. The region boasts significant R&D investment, a favorable regulatory environment, and a large concentration of pharmaceutical companies and research institutions, placing it at the forefront of technology development and clinical translation, and attracting substantial R&D collaborations and investments related to exosome delivery.
The global Exosome Drug Delivery Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
BOC Sciences
Cyagen
Immunostep
Magtech
CD Bioarticles
Fujifilm
Thermo Fisher Scientific
Danaher
Illumina
Theranostics
Takara Bio
Malvern Instruments
Miltenyi Biotec
MBL International
Lonza
Segment by Type
Intrinsic Loading
External Loading
Segment by Application
Pharmaceutical Companies
Laboratory
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Exosome Drug Delivery Services market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Exosome Drug Delivery Services value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Intrinsic Loading
1.2.3 External Loading
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Exosome Drug Delivery Services Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Exosome Drug Delivery Services Market Share by Revenue, by Region (2021-2026)
2.4 Global Exosome Drug Delivery Services Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Exosome Drug Delivery Services Market Size and Prospective (2021-2032)
2.5.2 Europe Exosome Drug Delivery Services Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Exosome Drug Delivery Services Market Size and Prospective (2021-2032)
2.5.4 Latin America Exosome Drug Delivery Services Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Exosome Drug Delivery Services Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Exosome Drug Delivery Services Historical Market Size by Type (2021-2026)
3.2 Global Exosome Drug Delivery Services Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Exosome Drug Delivery Services

4 Breakdown Data by Application
4.1 Global Exosome Drug Delivery Services Historical Market Size by Application (2021-2026)
4.2 Global Exosome Drug Delivery Services Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Exosome Drug Delivery Services Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Exosome Drug Delivery Services Players by Revenue (2021-2026)
5.1.2 Global Exosome Drug Delivery Services Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Exosome Drug Delivery Services Revenue
5.4 Global Exosome Drug Delivery Services Market Concentration Analysis
5.4.1 Global Exosome Drug Delivery Services Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Exosome Drug Delivery Services Revenue in 2025
5.5 Global Key Players of Exosome Drug Delivery Services Head Offices and Areas Served
5.6 Global Key Players of Exosome Drug Delivery Services, Product and Application
5.7 Global Key Players of Exosome Drug Delivery Services, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Exosome Drug Delivery Services Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Exosome Drug Delivery Services Market Size by Type (2021-2026)
6.1.2.2 North America Exosome Drug Delivery Services Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Exosome Drug Delivery Services Market Size by Application (2021-2026)
6.1.3.2 North America Exosome Drug Delivery Services Market Share by Application (2021-2026)
6.1.4 North America Exosome Drug Delivery Services Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Exosome Drug Delivery Services Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Exosome Drug Delivery Services Market Size by Type (2021-2026)
6.2.2.2 Europe Exosome Drug Delivery Services Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Exosome Drug Delivery Services Market Size by Application (2021-2026)
6.2.3.2 Europe Exosome Drug Delivery Services Market Share by Application (2021-2026)
6.2.4 Europe Exosome Drug Delivery Services Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Exosome Drug Delivery Services Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Exosome Drug Delivery Services Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Exosome Drug Delivery Services Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Exosome Drug Delivery Services Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Exosome Drug Delivery Services Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Exosome Drug Delivery Services Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Exosome Drug Delivery Services Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Exosome Drug Delivery Services Market Size by Type (2021-2026)
6.4.2.2 Latin America Exosome Drug Delivery Services Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Exosome Drug Delivery Services Market Size by Application (2021-2026)
6.4.3.2 Latin America Exosome Drug Delivery Services Market Share by Application (2021-2026)
6.4.4 Latin America Exosome Drug Delivery Services Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Exosome Drug Delivery Services Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Exosome Drug Delivery Services Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Exosome Drug Delivery Services Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Exosome Drug Delivery Services Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Exosome Drug Delivery Services Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Exosome Drug Delivery Services Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 BOC Sciences
7.1.1 BOC Sciences Company Details
7.1.2 BOC Sciences Business Overview
7.1.3 BOC Sciences Exosome Drug Delivery Services Introduction
7.1.4 BOC Sciences Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.1.5 BOC Sciences Recent Development
7.2 Cyagen
7.2.1 Cyagen Company Details
7.2.2 Cyagen Business Overview
7.2.3 Cyagen Exosome Drug Delivery Services Introduction
7.2.4 Cyagen Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.2.5 Cyagen Recent Development
7.3 Immunostep
7.3.1 Immunostep Company Details
7.3.2 Immunostep Business Overview
7.3.3 Immunostep Exosome Drug Delivery Services Introduction
7.3.4 Immunostep Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.3.5 Immunostep Recent Development
7.4 Magtech
7.4.1 Magtech Company Details
7.4.2 Magtech Business Overview
7.4.3 Magtech Exosome Drug Delivery Services Introduction
7.4.4 Magtech Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.4.5 Magtech Recent Development
7.5 CD Bioarticles
7.5.1 CD Bioarticles Company Details
7.5.2 CD Bioarticles Business Overview
7.5.3 CD Bioarticles Exosome Drug Delivery Services Introduction
7.5.4 CD Bioarticles Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.5.5 CD Bioarticles Recent Development
7.6 Fujifilm
7.6.1 Fujifilm Company Details
7.6.2 Fujifilm Business Overview
7.6.3 Fujifilm Exosome Drug Delivery Services Introduction
7.6.4 Fujifilm Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.6.5 Fujifilm Recent Development
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Details
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Exosome Drug Delivery Services Introduction
7.7.4 Thermo Fisher Scientific Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.7.5 Thermo Fisher Scientific Recent Development
7.8 Danaher
7.8.1 Danaher Company Details
7.8.2 Danaher Business Overview
7.8.3 Danaher Exosome Drug Delivery Services Introduction
7.8.4 Danaher Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.8.5 Danaher Recent Development
7.9 Illumina
7.9.1 Illumina Company Details
7.9.2 Illumina Business Overview
7.9.3 Illumina Exosome Drug Delivery Services Introduction
7.9.4 Illumina Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.9.5 Illumina Recent Development
7.10 Theranostics
7.10.1 Theranostics Company Details
7.10.2 Theranostics Business Overview
7.10.3 Theranostics Exosome Drug Delivery Services Introduction
7.10.4 Theranostics Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.10.5 Theranostics Recent Development
7.11 Takara Bio
7.11.1 Takara Bio Company Details
7.11.2 Takara Bio Business Overview
7.11.3 Takara Bio Exosome Drug Delivery Services Introduction
7.11.4 Takara Bio Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.11.5 Takara Bio Recent Development
7.12 Malvern Instruments
7.12.1 Malvern Instruments Company Details
7.12.2 Malvern Instruments Business Overview
7.12.3 Malvern Instruments Exosome Drug Delivery Services Introduction
7.12.4 Malvern Instruments Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.12.5 Malvern Instruments Recent Development
7.13 Miltenyi Biotec
7.13.1 Miltenyi Biotec Company Details
7.13.2 Miltenyi Biotec Business Overview
7.13.3 Miltenyi Biotec Exosome Drug Delivery Services Introduction
7.13.4 Miltenyi Biotec Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.13.5 Miltenyi Biotec Recent Development
7.14 MBL International
7.14.1 MBL International Company Details
7.14.2 MBL International Business Overview
7.14.3 MBL International Exosome Drug Delivery Services Introduction
7.14.4 MBL International Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.14.5 MBL International Recent Development
7.15 Lonza
7.15.1 Lonza Company Details
7.15.2 Lonza Business Overview
7.15.3 Lonza Exosome Drug Delivery Services Introduction
7.15.4 Lonza Revenue in Exosome Drug Delivery Services Business (2021-2026)
7.15.5 Lonza Recent Development

8 Exosome Drug Delivery Services Market Dynamics
8.1 Exosome Drug Delivery Services Industry Trends
8.2 Exosome Drug Delivery Services Market Drivers
8.3 Exosome Drug Delivery Services Market Challenges
8.4 Exosome Drug Delivery Services Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Exosome Drug Delivery Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Exosome Drug Delivery Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Exosome Drug Delivery Services Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Exosome Drug Delivery Services Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Exosome Drug Delivery Services Revenue Share by Region (2021-2026)
Table 6. Global Exosome Drug Delivery Services Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Exosome Drug Delivery Services Revenue Share Forecast by Region (2027-2032)
Table 8. Global Exosome Drug Delivery Services Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Exosome Drug Delivery Services Market Share by Revenue, by Type (2021-2026)
Table 10. Global Exosome Drug Delivery Services Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Exosome Drug Delivery Services Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Exosome Drug Delivery Services Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Exosome Drug Delivery Services Market Share by Revenue, by Application (2021-2026)
Table 15. Global Exosome Drug Delivery Services Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Exosome Drug Delivery Services Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Exosome Drug Delivery Services Applications
Table 18. Global Exosome Drug Delivery Services Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Exosome Drug Delivery Services Market Share by Players (2021-2026)
Table 20. Global Top Exosome Drug Delivery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Drug Delivery Services as of 2025)
Table 21. Ranking of Global Top Exosome Drug Delivery Services Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Exosome Drug Delivery Services Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Exosome Drug Delivery Services, Headquarters and Area Served
Table 24. Global Key Players of Exosome Drug Delivery Services, Product and Application
Table 25. Global Key Players of Exosome Drug Delivery Services, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Exosome Drug Delivery Services Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Exosome Drug Delivery Services Market Share by Revenue, by Company (2021-2026)
Table 29. North America Exosome Drug Delivery Services Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Exosome Drug Delivery Services Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Exosome Drug Delivery Services Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Exosome Drug Delivery Services Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Exosome Drug Delivery Services Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Exosome Drug Delivery Services Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Exosome Drug Delivery Services Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Exosome Drug Delivery Services Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Exosome Drug Delivery Services Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Exosome Drug Delivery Services Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Exosome Drug Delivery Services Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Exosome Drug Delivery Services Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Exosome Drug Delivery Services Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Exosome Drug Delivery Services Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Exosome Drug Delivery Services Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Exosome Drug Delivery Services Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Exosome Drug Delivery Services Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Exosome Drug Delivery Services Market Size by Application (2021-2026) & (US$ Million)
Table 47. BOC Sciences Company Details
Table 48. BOC Sciences Business Overview
Table 49. BOC Sciences Exosome Drug Delivery Services Product
Table 50. BOC Sciences Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 51. BOC Sciences Recent Development
Table 52. Cyagen Company Details
Table 53. Cyagen Business Overview
Table 54. Cyagen Exosome Drug Delivery Services Product
Table 55. Cyagen Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 56. Cyagen Recent Development
Table 57. Immunostep Company Details
Table 58. Immunostep Business Overview
Table 59. Immunostep Exosome Drug Delivery Services Product
Table 60. Immunostep Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 61. Immunostep Recent Development
Table 62. Magtech Company Details
Table 63. Magtech Business Overview
Table 64. Magtech Exosome Drug Delivery Services Product
Table 65. Magtech Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 66. Magtech Recent Development
Table 67. CD Bioarticles Company Details
Table 68. CD Bioarticles Business Overview
Table 69. CD Bioarticles Exosome Drug Delivery Services Product
Table 70. CD Bioarticles Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 71. CD Bioarticles Recent Development
Table 72. Fujifilm Company Details
Table 73. Fujifilm Business Overview
Table 74. Fujifilm Exosome Drug Delivery Services Product
Table 75. Fujifilm Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 76. Fujifilm Recent Development
Table 77. Thermo Fisher Scientific Company Details
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific Exosome Drug Delivery Services Product
Table 80. Thermo Fisher Scientific Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 81. Thermo Fisher Scientific Recent Development
Table 82. Danaher Company Details
Table 83. Danaher Business Overview
Table 84. Danaher Exosome Drug Delivery Services Product
Table 85. Danaher Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 86. Danaher Recent Development
Table 87. Illumina Company Details
Table 88. Illumina Business Overview
Table 89. Illumina Exosome Drug Delivery Services Product
Table 90. Illumina Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 91. Illumina Recent Development
Table 92. Theranostics Company Details
Table 93. Theranostics Business Overview
Table 94. Theranostics Exosome Drug Delivery Services Product
Table 95. Theranostics Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 96. Theranostics Recent Development
Table 97. Takara Bio Company Details
Table 98. Takara Bio Business Overview
Table 99. Takara Bio Exosome Drug Delivery Services Product
Table 100. Takara Bio Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 101. Takara Bio Recent Development
Table 102. Malvern Instruments Company Details
Table 103. Malvern Instruments Business Overview
Table 104. Malvern Instruments Exosome Drug Delivery Services Product
Table 105. Malvern Instruments Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 106. Malvern Instruments Recent Development
Table 107. Miltenyi Biotec Company Details
Table 108. Miltenyi Biotec Business Overview
Table 109. Miltenyi Biotec Exosome Drug Delivery Services Product
Table 110. Miltenyi Biotec Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 111. Miltenyi Biotec Recent Development
Table 112. MBL International Company Details
Table 113. MBL International Business Overview
Table 114. MBL International Exosome Drug Delivery Services Product
Table 115. MBL International Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 116. MBL International Recent Development
Table 117. Lonza Company Details
Table 118. Lonza Business Overview
Table 119. Lonza Exosome Drug Delivery Services Product
Table 120. Lonza Revenue in Exosome Drug Delivery Services Business (2021-2026) & (US$ Million)
Table 121. Lonza Recent Development
Table 122. Exosome Drug Delivery Services Market Trends
Table 123. Exosome Drug Delivery Services Market Drivers
Table 124. Exosome Drug Delivery Services Market Challenges
Table 125. Exosome Drug Delivery Services Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources

List of Figures
Figure 1. Exosome Drug Delivery Services Product Picture
Figure 2. Global Exosome Drug Delivery Services Market Share by Type: 2025 vs 2032
Figure 3. Intrinsic Loading Features
Figure 4. External Loading Features
Figure 5. Global Exosome Drug Delivery Services Market Share by Application: 2025 vs 2032
Figure 6. Pharmaceutical Companies
Figure 7. Laboratory
Figure 8. Others
Figure 9. Exosome Drug Delivery Services Report Years Considered
Figure 10. Global Exosome Drug Delivery Services Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 11. Global Exosome Drug Delivery Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Exosome Drug Delivery Services Market Share by Revenue, by Region: 2021 vs 2025
Figure 13. North America Exosome Drug Delivery Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 14. Europe Exosome Drug Delivery Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Asia-Pacific Exosome Drug Delivery Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Latin America Exosome Drug Delivery Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Middle East & Africa Exosome Drug Delivery Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Global Exosome Drug Delivery Services Market Share by Players in 2025
Figure 19. Global Top Exosome Drug Delivery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Drug Delivery Services as of 2025)
Figure 20. The Top 10 and 5 Players Market Share by Exosome Drug Delivery Services Revenue in 2025
Figure 21. North America Exosome Drug Delivery Services Market Share by Type (2021-2026)
Figure 22. North America Exosome Drug Delivery Services Market Share by Application (2021-2026)
Figure 23. Europe Exosome Drug Delivery Services Market Share by Type (2021-2026)
Figure 24. Europe Exosome Drug Delivery Services Market Share by Application (2021-2026)
Figure 25. Asia-Pacific Exosome Drug Delivery Services Market Share by Type (2021-2026)
Figure 26. Asia-Pacific Exosome Drug Delivery Services Market Share by Application (2021-2026)
Figure 27. Latin America Exosome Drug Delivery Services Market Share by Type (2021-2026)
Figure 28. Latin America Exosome Drug Delivery Services Market Share by Application (2021-2026)
Figure 29. Middle East & Africa Exosome Drug Delivery Services Market Share by Type (2021-2026)
Figure 30. Middle East & Africa Exosome Drug Delivery Services Market Share by Application (2021-2026)
Figure 31. BOC Sciences Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 32. Cyagen Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 33. Immunostep Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 34. Magtech Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 35. CD Bioarticles Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 36. Fujifilm Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 37. Thermo Fisher Scientific Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 38. Danaher Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 39. Illumina Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 40. Theranostics Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 41. Takara Bio Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 42. Malvern Instruments Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 43. Miltenyi Biotec Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 44. MBL International Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 45. Lonza Revenue Growth Rate in Exosome Drug Delivery Services Business (2021-2026)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed